American Vietnamese Biotech (HSTC:AMV) NonCurrent Deferred Liabilities: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is American Vietnamese Biotech NonCurrent Deferred Liabilities?

American Vietnamese Biotech HSTC:AMV NonCurrent Deferred Liabilities is ₫0.00 Mil as of . 20.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

American Vietnamese Biotech's non-current deferred liabilities for the quarter that ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech NonCurrent Deferred Liabilities Related Terms

American Vietnamese Biotech NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for American Vietnamese Biotech's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech NonCurrent Deferred Liabilities Chart

American Vietnamese Biotech Annual Data
Trend
NonCurrent Deferred Liabilities

American Vietnamese Biotech Quarterly Data
NonCurrent Deferred Liabilities
What does a NonCurrent Deferred Liabilities of ₫0.00 Mil mean?
American Vietnamese Biotech (HSTC:AMV) has a NonCurrent Deferred Liabilities of ₫0.00 Mil as of . 20. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on American Vietnamese Biotech and its competitors.
Is American Vietnamese Biotech's NonCurrent Deferred Liabilities too high?
American Vietnamese Biotech's current NonCurrent Deferred Liabilities is ₫0.00 Mil.
How does American Vietnamese Biotech's NonCurrent Deferred Liabilities compare to HSTC and STLT?
American Vietnamese Biotech's NonCurrent Deferred Liabilities of ₫0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on American Vietnamese Biotech and its competitors. American Vietnamese Biotech's current NonCurrent Deferred Liabilities is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Vietnamese Biotech stock overvalued right now?
American Vietnamese Biotech (HSTC:AMV) has a current NonCurrent Deferred Liabilities of ₫0.00 Mil. The current NonCurrent Deferred Liabilities is ₫0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For American Vietnamese Biotech (HSTC:AMV), the current NonCurrent Deferred Liabilities is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Vietnamese Biotech Business Description

Address No. 85 Hoang Van Thai, 4th Floor, Phu Ma Duong Building, Tan Phu Ward, District 7, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments, and chemicals; producing and trading vaccines and medical biological products.